1. Home
  2. BDSX vs GLU Comparison

BDSX vs GLU Comparison

Compare BDSX & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • GLU
  • Stock Information
  • Founded
  • BDSX 2005
  • GLU 2004
  • Country
  • BDSX United States
  • GLU United States
  • Employees
  • BDSX N/A
  • GLU N/A
  • Industry
  • BDSX Precision Instruments
  • GLU Finance/Investors Services
  • Sector
  • BDSX Health Care
  • GLU Finance
  • Exchange
  • BDSX Nasdaq
  • GLU Nasdaq
  • Market Cap
  • BDSX 115.4M
  • GLU 99.4M
  • IPO Year
  • BDSX 2020
  • GLU N/A
  • Fundamental
  • Price
  • BDSX $0.26
  • GLU $16.97
  • Analyst Decision
  • BDSX Strong Buy
  • GLU
  • Analyst Count
  • BDSX 5
  • GLU 0
  • Target Price
  • BDSX $1.75
  • GLU N/A
  • AVG Volume (30 Days)
  • BDSX 2.9M
  • GLU 12.4K
  • Earning Date
  • BDSX 08-06-2025
  • GLU 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • GLU 8.60%
  • EPS Growth
  • BDSX N/A
  • GLU N/A
  • EPS
  • BDSX N/A
  • GLU 0.62
  • Revenue
  • BDSX $74,463,000.00
  • GLU N/A
  • Revenue This Year
  • BDSX $17.29
  • GLU N/A
  • Revenue Next Year
  • BDSX $29.33
  • GLU N/A
  • P/E Ratio
  • BDSX N/A
  • GLU $22.50
  • Revenue Growth
  • BDSX 35.76
  • GLU N/A
  • 52 Week Low
  • BDSX $0.17
  • GLU $11.61
  • 52 Week High
  • BDSX $2.04
  • GLU $15.40
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 38.93
  • GLU 57.69
  • Support Level
  • BDSX $0.27
  • GLU $16.64
  • Resistance Level
  • BDSX $0.33
  • GLU $17.03
  • Average True Range (ATR)
  • BDSX 0.03
  • GLU 0.24
  • MACD
  • BDSX 0.01
  • GLU -0.01
  • Stochastic Oscillator
  • BDSX 19.54
  • GLU 86.05

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

Share on Social Networks: